David Lebwohl - 24 Sep 2021 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role: EVP, Chief Medical Officer
Signature: /s/James Basta, Attorney-in-fact
Issuer symbol: NTLA
Transactions as of: 24 Sep 2021
Net transactions value: +$99,988
Form type: 4
Filing time: 27 Sep 2021, 16:15:17 UTC
Previous filing: 23 Sep 2021
Next filing: 15 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NTLA	Common Stock	Options Exercise	$99,988	+7,923	+1002%	$12.62	8,714	24 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NTLA	Stock Option (right to buy)	Options Exercise	$0	-7,923	-4.1%	$0.000000	184,877	24 Sep 2021	Common Stock	7,923	$12.62	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 66,666 shares as of September 24, 2021.